Researchers are studying new methods that could improve the treatment of CML. Advances in cancer treatment and new ways to relieve side effects have resulted in increased quality of life and a better prognosis for many people with this disease.
Subjects discussed :
- Latest developments in CML research and their implications for patient care and quality of life
- Targeted treatments biomarkers
- What the future holds
Dr. David Sanford, MD, FRCPC
Clinical Assistant Professor, Division of Hematology
Department of Medicine, University of British Columbia
Tuesday July 10
11:15 Pacific Standard time
12:15 Mountain Daylight time
13:15 Central Daylight time
14:15 Eastern Daylight time
15:15 Atlantic Daylight time
15:45 Newfoundland Daylight time
Offered in English, this presentation will last 45 minutes with 15 minutes for Q&A.
Anyone interested must register in advance.
The French version of this webinar will be held on June 13, find more information here.